Simvastatin Ameliorates Diabetic Cardiomyopathy by Attenuating Oxidative Stress and Inflammation in Rats

Nawal M Al-Rasheed1,2, Nouf M Al-Rasheed1, Iman H Hasan1

  • 1Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.

Insights

Simvastatin treatment improved body weight and reduced hyperglycemia in diabetic rats with cardiomyopathy. The study found simvastatin alleviates diabetic cardiomyopathy by reducing oxidative stress, inflammation, and apoptosis.

Area of Science:

  • Cardiology
  • Endocrinology
  • Pharmacology

Background:

  • Diabetic cardiomyopathy (DCM) is a cardiac complication of diabetes.
  • Hyperglycemia-induced oxidative stress and inflammation contribute to DCM pathogenesis.

Purpose of the Study:

  • To investigate the protective effects of simvastatin on experimental diabetic cardiomyopathy.
  • To elucidate the mechanisms underlying simvastatin's action in DCM.

Main Methods:

  • Diabetes was induced in rats using streptozotocin.
  • Rats received simvastatin treatment for 90 days.
  • Cardiac function, oxidative stress markers, inflammatory mediators, and apoptosis were assessed.

Main Results:

  • Simvastatin improved body weight, attenuated hyperglycemia, and reduced cardiac hypertrophy in diabetic rats.
  • Simvastatin decreased cardiac injury markers (CK-MB, troponin I), lipid peroxidation, and inflammation (NF-κB).
  • Simvastatin reversed decreased antioxidant defenses and reduced cardiac caspase-3 activity.

Conclusions:

  • Simvastatin effectively alleviates experimental diabetic cardiomyopathy.
  • The cardioprotective effects are attributed to the attenuation of oxidative stress, inflammation, and apoptosis.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
460
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.5K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
493
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K